Concepedia

Julio Hajdenberg

JH

Statistics

Publications

18

Citations

1.4K

H-Index

15

Active since

2003

Affiliations

Orlando Health(Current)

Cornell University

UF Health Cancer Center

University of Florida Health

Memorial Sloan Kettering Cancer Center

Julio Hajdenberg is an author at Orlando Health specializing in medicine, oncology, and pharmacology.

Publications per year

2003–2023

18

Publications

18

Improved prevention of moderately emetogenic chemotherapy‐induced nausea and vomiting with palonosetron, a pharmacologically novel 5‐HT<sub>3</sub> receptor antagonist

Peter D. Eisenberg, Jazmin Figueroa‐Vadillo, Rosalio Zamora et al. · Cancer · 2003 · 404 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America

Walter M. Stadler, Robert A. Figlin, David F. McDermott et al. · Cancer · 2010 · 253 citations

Medicine, Oncology, Pharmacotherapy +16

Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non–Germinal Center B-Cell–Like Diffuse Large B-Cell Lymphoma

John P. Leonard, Kathryn S. Kolibaba, James A. Reeves et al. · Journal of Clinical Oncology · 2017 · 189 citations

Medicine, Hematology, Oncology +17

Sacituzumab Govitecan, a Novel Antibody–Drug Conjugate, in Patients With Metastatic Platinum-Resistant Urothelial Carcinoma

Bishoy M. Faltas, David M. Goldenberg, Allyson J. Ocean et al. · Clinical Genitourinary Cancer · 2015 · 105 citations · Full text

Medicine, Oncology, Pharmacology +15

Combination therapy for chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: palonosetron, dexamethasone, and aprepitant.

Thomas Grote, Julio Hajdenberg, Alan Cartmell et al. · PubMed · 2006 · 91 citations

Medicine, Pharmacology, Pharmacotherapy +17

1–5 of 18